Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

NOTCH1 pathway: a molecular target in T-cell cancers?

Lancet (London, England) - 1 Jan 2000

Holowiecki Jerzy

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloid Precursor Protein Secretases
Share to Aspartic Acid Endopeptidases
Share to Drug Delivery Systems
Share to Endopeptidases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia-Lymphoma, Adult T-Cell

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Share to Protease Inhibitors

Share to Receptor, Notch1

Source

Identifiers

PMID: 15652588
DOI: 10.1016/S0140-6736(05)17753-8

Genes

NOTCH1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

NOTCH1 pathway: a molecular target in T-cell cancers?PMID 15652588Read ↗

[The role and research progress of NOTCH1 in T-cell acute lymphoblastic leukemia].Semantic proximity Read ↗

Notch signaling pathway in cancer: from mechanistic insights to targeted therapiesSemantic proximity Read ↗

Notch in T-ALL: new players in a complex diseaseSemantic proximity Read ↗

The multifaceted role of Notch in cancer.Semantic proximity Read ↗

Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think.Semantic proximity Read ↗

Notch Pathway: A Journey from Notching Phenotypes to Cancer Immunotherapy.Semantic proximity Read ↗

Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia.Semantic proximity Read ↗

Notch Partners in the Long Journey of T-ALL Pathogenesis.Semantic proximity Read ↗

Notch Signaling Proteins: Legitimate Targets for Cancer TherapySemantic proximity Read ↗

The Notch ligand Jagged1 as a target for anti-tumor therapySemantic proximity Read ↗

Friend or foe: can activating mutations in NOTCH1 contribute to a favorable treatment outcome in patients with T-ALL?Semantic proximity Read ↗

Oncogenic Notch signaling in T-cell and B-cell lymphoproliferative disordersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.